Hormone Therapy

Top Story

Prescribing patterns for compounded HT differ across specialties

Prescribing patterns for compounded HT differ across specialties
July 18, 2016

Read the Perspective from JoAnn V. Pinkerton, MD, NCMP

In the United States, general practitioners and obstetrician/gynecologists are more likely to prescribe FDA-approved hormone therapy, whereas wellness practitioners are more likely to prescribe compounded hormone therapy, according to recent survey data.

“Some physician specialties are more likely to perceive a need to prescribe FDA unapproved products, that data from this survey may help to better understand the need for additional products to fill the gap that may lead some physician groups to prescribe products that are not fully studied or regulated,” Ginger D. Constantine, MD, of EndoRheum Consultants in Malvern, Pennsylvania, told Endocrine Today.

In the Journals

Vaginal estradiol softgel capsule viable option for atrophy symptoms

July 18, 2016
In postmenopausal women with moderate to severe vulvar and vaginal atrophy, a vaginal softgel suppository containing estradiol was a safe and effective treatment option…
In the Journals

GH therapy increases fracture risk in patients previously treated for acromegaly

July 15, 2016
Adult patients with severe growth hormone deficiency previously treated for acromegaly saw an increased fracture risk after 6 years of growth hormone replacement…
In the Journals

GnRHa therapy shows no effect on final height in girls with early puberty

July 11, 2016
In girls who experience moderately early puberty, gonadotropin-releasing human analogue treatment had no effect on final height, according to study findings published in…
CME Video

Navigating a New Era of Personalized Type 2 Diabetes Care: Taking the Road Less Traveled

This activity is supported by an independent educational grant from Boehringer-Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

In the United States, over 29 million people have diabetes, of which approximately 95% of cases are type 2 diabetes…
More »
Video
Meeting News Coverage

VIDEO: Testosterone Trials results announcement met with anticipation

April 7, 2016
More »
Featured
Highlights from AACE

Highlights from AACE

CME Video

Secondary Prevention of Atherothrombotic Events: Current Insights on Advancing Science

This activity is supported by an educational grant from Merck & Co.

Prevention of cardiovascular disease (CVD) is critical in light of its associated mortality, morbidity, and economic…
More »
In the JournalsPerspective

Prescribing patterns for compounded HT differ across specialties

July 18, 2016
In the United States, general practitioners and obstetrician/gynecologists are more likely to prescribe FDA-approved hormone therapy, whereas…

In the Journals

Vaginal estradiol softgel capsule viable option for atrophy symptoms

July 18, 2016
In postmenopausal women with moderate to severe vulvar and vaginal atrophy, a vaginal softgel suppository containing estradiol was a safe and…

In the Journals

GH therapy increases fracture risk in patients previously treated for acromegaly

July 15, 2016
Adult patients with severe growth hormone deficiency previously treated for acromegaly saw an increased fracture risk after 6 years of growth hormone…

In the Journals

GnRHa therapy shows no effect on final height in girls with early puberty

July 11, 2016
In girls who experience moderately early puberty, gonadotropin-releasing human analogue treatment had no effect on final height, according to study…

In the Journals

Adrenal volumes reduced, steroid hormone secretion increased after dexamethasone in PCOS

July 6, 2016
In some women with polycystic ovary syndrome, smaller adrenal volumes and higher steroid hormone secretion after dexamethasone therapy were detected…

In the Journals

Testosterone therapy effectively improves sexual activity in older men

June 29, 2016
Testosterone therapy consistently improved most types of sexual activity in symptomatic older men with low testosterone levels. “Our findings…

In the Journals

HT superior to oral contraceptives for increasing BMD in premature ovarian failure

June 28, 2016
In women with spontaneous premature ovarian failure, hormone therapy was shown to increase bone density at the lumbar spine at a greater rate vs…

In the Journals

Estradiol deficiency may mediate vasomotor symptoms in men with hypogonadism

June 23, 2016
Vasomotor symptoms in men with hypogonadism may be mediated be estradiol deficiency and high levels of testosterone may suppress the effects…

In the Journals

High prevalence of altered glucose metabolism observed in Prader-Willi syndrome

June 22, 2016
Italian adults with Prader-Willi syndrome and obesity are at increased risk for altered glucose metabolism as they get older, when the frequency of…

Meeting News Coverage

Estrogen therapy increases BMD in transgender women

June 1, 2016
In transgender women, estrogen therapy was shown to increase bone mineral density in both the lumbar spine and total hip during the first year of…

More Headlines »